BEACOPP regimen
|
WikiDoc Resources for BEACOPP regimen |
|
Articles |
|---|
|
Most recent articles on BEACOPP regimen Most cited articles on BEACOPP regimen |
|
Media |
|
Powerpoint slides on BEACOPP regimen |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on BEACOPP regimen at Clinical Trials.gov Trial results on BEACOPP regimen Clinical Trials on BEACOPP regimen at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on BEACOPP regimen NICE Guidance on BEACOPP regimen
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on BEACOPP regimen Discussion groups on BEACOPP regimen Patient Handouts on BEACOPP regimen Directions to Hospitals Treating BEACOPP regimen Risk calculators and risk factors for BEACOPP regimen
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for BEACOPP regimen |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Overview
BEACOPP is a chemotherapy regimen for treatment of Hodgkin's lymphoma in Stages > II. Patients typically receive treatment in cycles of 21 days with no drugs given on days 16-21. There also exists a more intensive regimen with cycles of 14 days. Usually a therapy consists of eight, sometimes six cycles. In some countries BEACOPP still is experimental, in others (eg. Germany and Austria) it is a standard therapy. The reason that the United States physicians still use ABVD (or Stanford V) is that they think that BEACOPP induces more secondary neoplasias as leukemias, etc. However, this (after 10 years of experience) is not the case. BEACOPP delivers approximately 10-15% more cures in advanced Hodgkins disease (IIB+risk factors or stages III and IV). BEACOPP is more expensive as it requires G-CSF support. However, it is well worth it because of the higher cure rates.
m² = body surface
i.v.=intravenous
BEACOPP basic:
| (C)yclophosphamide | 650 mg/m² | (i.v.) | day 1 |
| (A)driamycin | 25 mg/m² | i.v. | day 1 |
| (E)toposide | 100 mg/m² | i.v. | day 1-3 |
| Vincristin(=(O)ncovin) | 1,4 mg/m² (max 2 mg) | i.v. | day 8 |
| (B)leomycin | 10 mg/m² | i.v. | day 8 |
| (P)rocarbazine | 100 mg/m² | orally | day 1-7 |
| (P)rednisone | 40 mg/m² | orally | day 1-14 |
BEACOPP escalated:
| Cyclophosphamide | 1250 mg/m² KO/day | i.v. | day 1 |
| Adriamycin | 35 mg/m² | i.v. | day 1 |
| Etoposide | 200 mg/m² | i.v. | day 1-3 |
| Vincristine | 1,4 mg/m² (max 2 mg) | i.v. | day 8 |
| Bleomycin | 10 mg/m² | i.v. | day 8 |
| Procarbazine | 100 mg/m² | orally | day 1-7 |
| Prednisone | 40 mg/m² | orally | day 1-14 |